Dynamic Advisor Solutions LLC Sells 344 Shares of Danaher Co. (NYSE:DHR)

Dynamic Advisor Solutions LLC decreased its stake in shares of Danaher Co. (NYSE:DHRGet Rating) by 8.8% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,564 shares of the conglomerate’s stock after selling 344 shares during the quarter. Dynamic Advisor Solutions LLC’s holdings in Danaher were worth $1,045,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in DHR. Dark Forest Capital Management LP bought a new stake in shares of Danaher in the 3rd quarter valued at about $33,000. Tudor Investment Corp Et Al bought a new stake in shares of Danaher in the 3rd quarter valued at about $406,000. EP Wealth Advisors LLC raised its holdings in shares of Danaher by 106.8% in the 3rd quarter. EP Wealth Advisors LLC now owns 4,204 shares of the conglomerate’s stock valued at $585,000 after purchasing an additional 2,171 shares in the last quarter. Kozak & Associates Inc. bought a new stake in shares of Danaher in the 3rd quarter valued at about $45,000. Finally, Cetera Advisors LLC raised its holdings in shares of Danaher by 17.2% in the 3rd quarter. Cetera Advisors LLC now owns 15,664 shares of the conglomerate’s stock valued at $4,769,000 after purchasing an additional 2,295 shares in the last quarter. Institutional investors own 78.42% of the company’s stock.

NYSE:DHR opened at $245.91 on Thursday. The company has a market cap of $178.80 billion, a PE ratio of 28.46, a P/E/G ratio of 2.71 and a beta of 0.84. Danaher Co. has a twelve month low of $233.71 and a twelve month high of $333.96. The company has a current ratio of 1.68, a quick ratio of 1.27 and a debt-to-equity ratio of 0.51. The company’s 50 day moving average is $255.02 and its two-hundred day moving average is $278.47.

Danaher (NYSE:DHRGet Rating) last released its earnings results on Thursday, April 21st. The conglomerate reported $2.76 earnings per share for the quarter, topping the consensus estimate of $2.65 by $0.11. The company had revenue of $7.69 billion for the quarter, compared to the consensus estimate of $7.53 billion. Danaher had a net margin of 21.32% and a return on equity of 18.64%. Danaher’s revenue was up 11.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.52 EPS. As a group, analysts expect that Danaher Co. will post 10.31 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 29th. Shareholders of record on Friday, June 24th will be paid a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 0.41%. The ex-dividend date of this dividend is Thursday, June 23rd. Danaher’s payout ratio is 11.57%.

In related news, EVP Joakim Weidemanis sold 6,500 shares of the business’s stock in a transaction on Monday, April 25th. The shares were sold at an average price of $255.74, for a total value of $1,662,310.00. Following the completion of the transaction, the executive vice president now directly owns 86,398 shares in the company, valued at approximately $22,095,424.52. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 11.20% of the company’s stock.

Several equities research analysts have recently commented on DHR shares. UBS Group reduced their price target on shares of Danaher from $365.00 to $340.00 in a report on Sunday, April 24th. Royal Bank of Canada raised shares of Danaher from a “sector perform” rating to an “outperform” rating and lifted their price objective for the stock from $299.00 to $310.00 in a research report on Wednesday, June 1st. StockNews.com downgraded shares of Danaher from a “buy” rating to a “hold” rating in a research report on Friday, April 22nd. Wells Fargo & Company downgraded shares of Danaher from an “overweight” rating to an “equal weight” rating and cut their price objective for the stock from $330.00 to $265.00 in a research report on Monday, April 25th. Finally, William Blair reaffirmed an “outperform” rating on shares of Danaher in a research report on Friday, April 22nd. Two equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $336.08.

Danaher Profile (Get Rating)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy.

Featured Stories

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Want More Great Investing Ideas?

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.